Ares Systematic Credit’s Pediatrix Medical MD Stock Holding History

Ares Systematic Credit’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$96.1K	Buy	+3,793	New	+$86.3K	0.06%	222

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Ares Systematic Credit's MD Position: Q2 2026 in Review

Ares Systematic Credit opened a new position in Pediatrix Medical (MD) in Q2 2026: 3,793 shares worth $96.1K. The stake represents 0.06% of the portfolio and ranks #222 among its holdings.

302 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Ares Systematic Credit held 3,793 shares of Pediatrix Medical worth $96.1K as of Q2 2026.
Pediatrix Medical was a new Ares Systematic Credit position in Q2 2026.
Pediatrix Medical made up 0.06% of Ares Systematic Credit's portfolio in Q2 2026, its #222 holding.
302 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Ares Systematic Credit's 13F filing for Q2 2026, filed 14 Aug 2026.